Bodi Envi review

What it is

Bodi Envi is a nationwide telehealth weight-loss practice founded by Ashley and Shaun Padgett, former owners of a Florida brick-and-mortar clinic. Its core products are compounded semaglutide and tirzepatide at flat all-dose monthly pricing, with micro-dose options and anti-nausea support for eligible patients. It also sells an NAD⁺ injection at its own published monthly price, which is why it appears on this board. Medication is compounded through its named pharmacy partner VialsRx, and plans are FSA/HSA eligible with free two-day shipping.

How it works

Same-day telehealth visits, 24/7 secure provider messaging and personalised dose titration, with no consultation or membership fee layered on top of the medication price — a structure that removes most of the fee games common in this category, and one where ongoing clinician contact is part of the product rather than an upsell. Cancel-anytime terms with no long-term contract are stated. Naming VialsRx as the compounding pharmacy is the disclosure we look for and rarely find. The gaps are narrower than most here but real: no state list is published, with coverage described as nationwide and features varying by state; no LegitScript certification is displayed; and the NAD⁺ product itself comes with no published protocol, route detail or monitoring plan — it is an add-on to a weight-loss practice rather than the practice's subject.

Pricing transparency

Bodi Envi publishes an NAD⁺ injection at $130/mo, which is the figure on our board and one of the lowest published NAD⁺ prices we have found anywhere. Its GLP-1 pricing is published as explicitly flat across all doses, which means titrating up does not raise the bill — a structure worth crediting, though it is a weight-loss figure and not the NAD⁺ one. There are no consultation or membership fees, shipping is free and two-day, plans are FSA/HSA eligible and financing is offered. Before enrolling, confirm what dose and route $130 supplies, whether it holds on refills, and whether the NAD⁺ is billed alongside a GLP-1 plan or can stand alone.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Bodi Envi carries an explicit compounding disclaimer on its own site, and its products are compounded through VialsRx, which it names and describes as licensed in all 50 states — an identifiable facility is one whose licensure you can actually look into, which matters because compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. On the evidence, the NAD⁺ product needs the same treatment as everywhere else on this board. Injected NAD⁺ has no controlled human outcome trials supporting the energy, recovery or longevity claims the category runs on, and the single human intravenous study was a pharmacokinetic pilot that found infused NAD⁺ clears from plasma quickly. The NAD⁺ forms with human trial data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker, not a demonstrated clinical outcome. A well-run practice selling an unproven product is still selling an unproven product. Individual results vary.

Pros and watch-outs

The evidence behind what Bodi Envi prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How Bodi Envi compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Invigor Medical

  Prescription at-home NAD⁺ injections via telehealth

  See Invigor Medical →
• TNTru Niagen

  The most clinically-studied oral NAD⁺ precursor (NR)

  See Tru Niagen →
• RHRestore Hyper Wellness

  In-person NAD⁺ IV or IM shots at a national studio chain

  See Restore Hyper Wellness →